Can Ustekinumab (Stelara) cause blood samples to clump?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

There is no evidence that ustekinumab (Stelara) directly causes blood samples to clump. Ustekinumab is a monoclonal antibody that targets interleukin-12 and interleukin-23, used to treat conditions like psoriasis, psoriatic arthritis, and Crohn's disease. Blood sample clumping, also known as agglutination, is not listed among the known side effects of this medication in clinical trials or post-marketing surveillance, as seen in studies such as 1 which focused on the pharmacokinetics and exposure response of ustekinumab in patients with ulcerative colitis, without mentioning any effects on blood sample clumping.

If you're experiencing issues with blood samples clumping during laboratory testing while on ustekinumab, this is more likely due to other factors such as:

  • Improper sample collection technique
  • Delayed processing of samples
  • Exposure to extreme temperatures
  • Underlying medical conditions that affect blood properties

Studies like 2, 3, 4, and 5 provide insights into the efficacy, safety, and immunogenicity of ustekinumab but do not report any association with blood sample clumping. For instance, 2 discusses the efficacy and safety of ustekinumab in patients with active systemic lupus erythematosus, while 3 analyzes the positive treatment effects of ustekinumab in psoriasis, and 4 reports a case of diffuse alveolar hemorrhage associated with ustekinumab treatment, none of which mention blood sample clumping as a side effect. Similarly, 5 investigates the association between clinical response to ustekinumab and immunogenicity to ustekinumab and prior adalimumab, without any reference to effects on blood samples.

If you notice persistent problems with blood tests while taking ustekinumab, it's essential to discuss this with your healthcare provider, as they may need to investigate other potential causes or adjust the timing of blood draws in relation to your medication schedule. However, you should continue taking your prescribed dose of ustekinumab unless specifically instructed otherwise by your doctor.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.